Topics

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More

09:00 EST 8 Nov 2019 | Xconomy

During the state of the union address this year, President Trump pledged to end HIV transmission within the next decade. A key part of that plan is an HIV prevention drug made by Gilead Sciences. That drug has now become the center of a patent dispute between the Foster City, CA, drug maker and the […]

Original Article: Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More

NEXT ARTICLE

More From BioPortfolio on "Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More"

Quick Search

Relevant Topics

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...